Physician profile

Raul Ortega

Vascular Surgery · Denton, TX

NPI 1295902385

$8,384.07

in general payments reported to CMS, 2019-2025

31 companies · $2,406 in 2025

The $2,406 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,706.97

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
W. L. Gore & Associates, INC. $2,339.71 2019-2025 Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis
Endologix LLC $1,208.41 2019-2025 Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System
Inari Medical, INC. $1,141.88 2021-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Tactile Systems Technology INC $665.51 2019-2025 Flexitouch Plus, Entre Plus, Nimbl
Lemaitre Vascular, INC. $632.42 2019-2024 Trivex System
Silk Road Medical, INC. $567.62 2019-2024 Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter
Bolton Medical INC $298.78 2020-2025 Treo Abdominal Stent-Graft System
Stryker Corporation $256.11 2025 Clottriever Bold Catheter, Flowtriever
Novartis Pharmaceuticals Corporation $161.44 2021-2023
Penumbra, INC. $152.54 2023 Ruby Coil
Laminate Medical Technologies INC. $130.00 2025 Vasq
Cook Medical LLC $111.17 2019-2024 Tornado
Ethicon US, LLC $95.96 2021-2024 Prolene, Echelon Endopath, Evarrest
Medtronic, INC. $85.41 2021-2023 In.Pact Av, Abre, Plasmablade(Tm)
Atricure, INC. $68.62 2019
Show all 31 companies
CompanyGeneral paymentsYearsTop products
Imperative Care, INC $60.29 2025 Symphony Catheter
Smith+Nephew, INC. $54.70 2020-2025 Versajet, Collagenase Santyl
Reflow Medical INC $46.98 2025
Pfizer INC. $44.39 2022-2024
Janssen Pharmaceuticals, INC $38.15 2021-2022
Abiomed $34.89 2024 Impella
Pacira Pharmaceuticals Incorporated $34.45 2025 Exparel
Ossur Americas, INC. $24.86 2025
Terumo Medical Corporation $19.52 2024 Glidesheath Slender, R2p Misago, Metacross Otw
Kci USA, INC. $19.38 2019
Shockwave Medical, INC $18.08 2025
Cvrx, INC. $16.24 2024 Barostim Neo System
Boston Scientific Corporation $16.00 2025 Enhance Transcarotid Peripheral Access Kit
Cardinal Health 200 LLC $15.59 2019
Cashflow Solutions, LLC $13.09 2023 Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White
Merck Sharp & Dohme LLC $11.88 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Raul Ortega

$8,384.07

in general payments reported 2019-2025

Years
2019-2025
Top company
W. L. Gore & Associates, INC.
Context
The $2,406 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).

https://glasscript.com/doctor/331531/raul-ortega

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.